nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—Hepatic encephalopathy—Furosemide—dilated cardiomyopathy	0.0448	0.0467	CcSEcCtD
Rabeprazole—Hepatic cirrhosis—Furosemide—dilated cardiomyopathy	0.0339	0.0353	CcSEcCtD
Rabeprazole—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0194	0.0202	CcSEcCtD
Rabeprazole—Tendon disorder—Lisinopril—dilated cardiomyopathy	0.0187	0.0195	CcSEcCtD
Rabeprazole—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0184	0.0192	CcSEcCtD
Rabeprazole—Breast pain—Spironolactone—dilated cardiomyopathy	0.0137	0.0143	CcSEcCtD
Rabeprazole—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.011	0.0114	CcSEcCtD
Rabeprazole—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0107	0.0111	CcSEcCtD
Rabeprazole—Eruption—Furosemide—dilated cardiomyopathy	0.0106	0.011	CcSEcCtD
Rabeprazole—Drug eruption—Furosemide—dilated cardiomyopathy	0.0106	0.011	CcSEcCtD
Rabeprazole—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0102	0.0107	CcSEcCtD
Rabeprazole—Bursitis—Lisinopril—dilated cardiomyopathy	0.0101	0.0105	CcSEcCtD
Rabeprazole—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.00962	0.01	CcSEcCtD
Rabeprazole—Thrombosis—Furosemide—dilated cardiomyopathy	0.00918	0.00956	CcSEcCtD
Rabeprazole—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00903	0.00941	CcSEcCtD
Rabeprazole—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.00848	0.00884	CcSEcCtD
Rabeprazole—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00808	0.00842	CcSEcCtD
Rabeprazole—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.00801	0.00835	CcSEcCtD
Rabeprazole—Injection site pain—Furosemide—dilated cardiomyopathy	0.00796	0.00829	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0078	0.00813	CcSEcCtD
Rabeprazole—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00775	0.00808	CcSEcCtD
Rabeprazole—Gastritis—Spironolactone—dilated cardiomyopathy	0.00767	0.00799	CcSEcCtD
Rabeprazole—Gout—Furosemide—dilated cardiomyopathy	0.00696	0.00725	CcSEcCtD
Rabeprazole—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0069	0.00719	CcSEcCtD
Rabeprazole—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00676	0.00705	CcSEcCtD
Rabeprazole—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00676	0.00705	CcSEcCtD
Rabeprazole—ATP4B—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.00672	0.166	CbGpPWpGaD
Rabeprazole—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00662	0.0069	CcSEcCtD
Rabeprazole—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00647	0.00675	CcSEcCtD
Rabeprazole—Otitis media—Lisinopril—dilated cardiomyopathy	0.00626	0.00652	CcSEcCtD
Rabeprazole—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00623	0.0065	CcSEcCtD
Rabeprazole—ATP4A—Ion transport by P-type ATPases—PLN—dilated cardiomyopathy	0.00599	0.148	CbGpPWpGaD
Rabeprazole—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00597	0.00622	CcSEcCtD
Rabeprazole—Urine output increased—Furosemide—dilated cardiomyopathy	0.00587	0.00612	CcSEcCtD
Rabeprazole—Bladder pain—Furosemide—dilated cardiomyopathy	0.00587	0.00612	CcSEcCtD
Rabeprazole—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00567	0.00591	CcSEcCtD
Rabeprazole—Breast pain—Lisinopril—dilated cardiomyopathy	0.00559	0.00582	CcSEcCtD
Rabeprazole—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00545	0.00568	CcSEcCtD
Rabeprazole—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00542	0.00565	CcSEcCtD
Rabeprazole—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.0054	0.00562	CcSEcCtD
Rabeprazole—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00537	0.0056	CcSEcCtD
Rabeprazole—Polyuria—Furosemide—dilated cardiomyopathy	0.00537	0.0056	CcSEcCtD
Rabeprazole—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00536	0.00559	CcSEcCtD
Rabeprazole—Alopecia—Spironolactone—dilated cardiomyopathy	0.0053	0.00552	CcSEcCtD
Rabeprazole—Deafness—Furosemide—dilated cardiomyopathy	0.00527	0.00549	CcSEcCtD
Rabeprazole—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00522	0.00544	CcSEcCtD
Rabeprazole—Gout—Lisinopril—dilated cardiomyopathy	0.00522	0.00544	CcSEcCtD
Rabeprazole—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00519	0.0054	CcSEcCtD
Rabeprazole—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00502	0.00523	CcSEcCtD
Rabeprazole—Thirst—Furosemide—dilated cardiomyopathy	0.00495	0.00516	CcSEcCtD
Rabeprazole—Neck pain—Lisinopril—dilated cardiomyopathy	0.00493	0.00514	CcSEcCtD
Rabeprazole—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.00487	0.00508	CcSEcCtD
Rabeprazole—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00487	0.00508	CcSEcCtD
Rabeprazole—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00484	0.00505	CcSEcCtD
Rabeprazole—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00476	0.00496	CcSEcCtD
Rabeprazole—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00473	0.00493	CcSEcCtD
Rabeprazole—Malaise—Spironolactone—dilated cardiomyopathy	0.00471	0.00491	CcSEcCtD
Rabeprazole—Cystitis—Lisinopril—dilated cardiomyopathy	0.00471	0.0049	CcSEcCtD
Rabeprazole—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00467	0.00487	CcSEcCtD
Rabeprazole—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00458	0.00477	CcSEcCtD
Rabeprazole—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00441	0.00459	CcSEcCtD
Rabeprazole—Discomfort—Spironolactone—dilated cardiomyopathy	0.00439	0.00458	CcSEcCtD
Rabeprazole—Dehydration—Furosemide—dilated cardiomyopathy	0.00439	0.00457	CcSEcCtD
Rabeprazole—Confusional state—Spironolactone—dilated cardiomyopathy	0.0043	0.00448	CcSEcCtD
Rabeprazole—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00429	0.00447	CcSEcCtD
Rabeprazole—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00427	0.00445	CcSEcCtD
Rabeprazole—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00426	0.00444	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00425	0.00443	CcSEcCtD
Rabeprazole—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00417	0.00435	CcSEcCtD
Rabeprazole—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0041	0.00428	CcSEcCtD
Rabeprazole—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00409	0.00426	CcSEcCtD
Rabeprazole—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00407	0.00424	CcSEcCtD
Rabeprazole—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00405	0.00422	CcSEcCtD
Rabeprazole—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00403	0.0042	CcSEcCtD
Rabeprazole—Pancreatitis—Furosemide—dilated cardiomyopathy	0.004	0.00416	CcSEcCtD
Rabeprazole—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00399	0.00416	CcSEcCtD
Rabeprazole—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00392	0.00408	CcSEcCtD
Rabeprazole—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00382	0.00398	CcSEcCtD
Rabeprazole—Somnolence—Spironolactone—dilated cardiomyopathy	0.00379	0.00395	CcSEcCtD
Rabeprazole—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00376	0.00392	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00372	0.00388	CcSEcCtD
Rabeprazole—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00368	0.00383	CcSEcCtD
Rabeprazole—Arthritis—Lisinopril—dilated cardiomyopathy	0.00364	0.00379	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0036	0.00375	CcSEcCtD
Rabeprazole—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00355	0.0037	CcSEcCtD
Rabeprazole—Diplopia—Lisinopril—dilated cardiomyopathy	0.00354	0.00369	CcSEcCtD
Rabeprazole—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00354	0.00369	CcSEcCtD
Rabeprazole—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00351	0.00366	CcSEcCtD
Rabeprazole—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00351	0.00366	CcSEcCtD
Rabeprazole—Sweating—Furosemide—dilated cardiomyopathy	0.00348	0.00363	CcSEcCtD
Rabeprazole—Face oedema—Lisinopril—dilated cardiomyopathy	0.00342	0.00356	CcSEcCtD
Rabeprazole—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00339	0.00353	CcSEcCtD
Rabeprazole—Urticaria—Spironolactone—dilated cardiomyopathy	0.00338	0.00353	CcSEcCtD
Rabeprazole—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00337	0.00351	CcSEcCtD
Rabeprazole—Dehydration—Lisinopril—dilated cardiomyopathy	0.00329	0.00343	CcSEcCtD
Rabeprazole—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00322	0.00336	CcSEcCtD
Rabeprazole—Urethral disorder—Furosemide—dilated cardiomyopathy	0.0032	0.00333	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00319	0.00332	CcSEcCtD
Rabeprazole—Visual impairment—Furosemide—dilated cardiomyopathy	0.00314	0.00328	CcSEcCtD
Rabeprazole—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00314	0.00327	CcSEcCtD
Rabeprazole—Gastritis—Lisinopril—dilated cardiomyopathy	0.00313	0.00326	CcSEcCtD
Rabeprazole—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00308	0.00321	CcSEcCtD
Rabeprazole—Asthma—Lisinopril—dilated cardiomyopathy	0.00306	0.00319	CcSEcCtD
Rabeprazole—Eye disorder—Furosemide—dilated cardiomyopathy	0.00305	0.00318	CcSEcCtD
Rabeprazole—Tinnitus—Furosemide—dilated cardiomyopathy	0.00304	0.00317	CcSEcCtD
Rabeprazole—Pruritus—Spironolactone—dilated cardiomyopathy	0.00301	0.00314	CcSEcCtD
Rabeprazole—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.003	0.00312	CcSEcCtD
Rabeprazole—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00298	0.0031	CcSEcCtD
Rabeprazole—Angiopathy—Furosemide—dilated cardiomyopathy	0.00296	0.00308	CcSEcCtD
Rabeprazole—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00294	0.00306	CcSEcCtD
Rabeprazole—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00291	0.00304	CcSEcCtD
Rabeprazole—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00291	0.00304	CcSEcCtD
Rabeprazole—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.0029	0.00303	CcSEcCtD
Rabeprazole—Dysuria—Lisinopril—dilated cardiomyopathy	0.00286	0.00298	CcSEcCtD
Rabeprazole—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00286	0.00298	CcSEcCtD
Rabeprazole—Erythema—Furosemide—dilated cardiomyopathy	0.00284	0.00296	CcSEcCtD
Rabeprazole—Malnutrition—Furosemide—dilated cardiomyopathy	0.00284	0.00296	CcSEcCtD
Rabeprazole—Dizziness—Spironolactone—dilated cardiomyopathy	0.00282	0.00294	CcSEcCtD
Rabeprazole—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00282	0.00293	CcSEcCtD
Rabeprazole—Flatulence—Furosemide—dilated cardiomyopathy	0.0028	0.00292	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00279	0.00291	CcSEcCtD
Rabeprazole—Weight increased—Lisinopril—dilated cardiomyopathy	0.00278	0.0029	CcSEcCtD
Rabeprazole—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00278	0.0029	CcSEcCtD
Rabeprazole—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00277	0.00288	CcSEcCtD
Rabeprazole—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00276	0.00287	CcSEcCtD
Rabeprazole—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00274	0.00286	CcSEcCtD
Rabeprazole—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00273	0.00285	CcSEcCtD
Rabeprazole—Vomiting—Spironolactone—dilated cardiomyopathy	0.00271	0.00282	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.0027	0.00282	CcSEcCtD
Rabeprazole—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00269	0.0028	CcSEcCtD
Rabeprazole—Rash—Spironolactone—dilated cardiomyopathy	0.00269	0.0028	CcSEcCtD
Rabeprazole—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00268	0.0028	CcSEcCtD
Rabeprazole—Vision blurred—Furosemide—dilated cardiomyopathy	0.00268	0.00279	CcSEcCtD
Rabeprazole—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00267	0.00279	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00267	0.00279	CcSEcCtD
Rabeprazole—Headache—Spironolactone—dilated cardiomyopathy	0.00267	0.00278	CcSEcCtD
Rabeprazole—Jaundice—Lisinopril—dilated cardiomyopathy	0.00266	0.00277	CcSEcCtD
Rabeprazole—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00265	0.00276	CcSEcCtD
Rabeprazole—Anaemia—Furosemide—dilated cardiomyopathy	0.00262	0.00274	CcSEcCtD
Rabeprazole—Sweating—Lisinopril—dilated cardiomyopathy	0.00261	0.00272	CcSEcCtD
Rabeprazole—Agitation—Furosemide—dilated cardiomyopathy	0.00261	0.00272	CcSEcCtD
Rabeprazole—Haematuria—Lisinopril—dilated cardiomyopathy	0.0026	0.00271	CcSEcCtD
Rabeprazole—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00257	0.00268	CcSEcCtD
Rabeprazole—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00256	0.00267	CcSEcCtD
Rabeprazole—Vertigo—Furosemide—dilated cardiomyopathy	0.00255	0.00266	CcSEcCtD
Rabeprazole—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00254	0.00265	CcSEcCtD
Rabeprazole—Leukopenia—Furosemide—dilated cardiomyopathy	0.00254	0.00265	CcSEcCtD
Rabeprazole—Nausea—Spironolactone—dilated cardiomyopathy	0.00253	0.00264	CcSEcCtD
Rabeprazole—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00249	0.0026	CcSEcCtD
Rabeprazole—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00245	0.00256	CcSEcCtD
Rabeprazole—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00245	0.00255	CcSEcCtD
Rabeprazole—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00243	0.00253	CcSEcCtD
Rabeprazole—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00242	0.00252	CcSEcCtD
Rabeprazole—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00241	0.00251	CcSEcCtD
Rabeprazole—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.0024	0.0025	CcSEcCtD
Rabeprazole—ATP4B—Ion channel transport—RYR2—dilated cardiomyopathy	0.00239	0.0592	CbGpPWpGaD
Rabeprazole—Dry mouth—Furosemide—dilated cardiomyopathy	0.00236	0.00246	CcSEcCtD
Rabeprazole—Confusional state—Furosemide—dilated cardiomyopathy	0.00234	0.00244	CcSEcCtD
Rabeprazole—ATP4B—Ion channel transport—PLN—dilated cardiomyopathy	0.00233	0.0576	CbGpPWpGaD
Rabeprazole—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00232	0.00242	CcSEcCtD
Rabeprazole—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00231	0.00241	CcSEcCtD
Rabeprazole—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00228	0.00238	CcSEcCtD
Rabeprazole—Shock—Furosemide—dilated cardiomyopathy	0.00228	0.00238	CcSEcCtD
Rabeprazole—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00227	0.00236	CcSEcCtD
Rabeprazole—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00224	0.00233	CcSEcCtD
Rabeprazole—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00222	0.00231	CcSEcCtD
Rabeprazole—Anorexia—Furosemide—dilated cardiomyopathy	0.00221	0.0023	CcSEcCtD
Rabeprazole—Chills—Lisinopril—dilated cardiomyopathy	0.0022	0.00229	CcSEcCtD
Rabeprazole—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00219	0.00228	CcSEcCtD
Rabeprazole—Hypotension—Furosemide—dilated cardiomyopathy	0.00217	0.00226	CcSEcCtD
Rabeprazole—Alopecia—Lisinopril—dilated cardiomyopathy	0.00216	0.00225	CcSEcCtD
Rabeprazole—ATP4A—Ion channel transport—RYR2—dilated cardiomyopathy	0.00213	0.0527	CbGpPWpGaD
Rabeprazole—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00213	0.00222	CcSEcCtD
Rabeprazole—Erythema—Lisinopril—dilated cardiomyopathy	0.00213	0.00222	CcSEcCtD
Rabeprazole—Flatulence—Lisinopril—dilated cardiomyopathy	0.0021	0.00219	CcSEcCtD
Rabeprazole—Tension—Lisinopril—dilated cardiomyopathy	0.00209	0.00218	CcSEcCtD
Rabeprazole—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00209	0.00217	CcSEcCtD
Rabeprazole—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00208	0.00217	CcSEcCtD
Rabeprazole—ATP4A—Ion channel transport—PLN—dilated cardiomyopathy	0.00207	0.0513	CbGpPWpGaD
Rabeprazole—Nervousness—Lisinopril—dilated cardiomyopathy	0.00207	0.00216	CcSEcCtD
Rabeprazole—Back pain—Lisinopril—dilated cardiomyopathy	0.00206	0.00215	CcSEcCtD
Rabeprazole—Somnolence—Furosemide—dilated cardiomyopathy	0.00206	0.00215	CcSEcCtD
Rabeprazole—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00205	0.00213	CcSEcCtD
Rabeprazole—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00201	0.0021	CcSEcCtD
Rabeprazole—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00201	0.00209	CcSEcCtD
Rabeprazole—Tremor—Lisinopril—dilated cardiomyopathy	0.002	0.00208	CcSEcCtD
Rabeprazole—Constipation—Furosemide—dilated cardiomyopathy	0.00198	0.00207	CcSEcCtD
Rabeprazole—Pain—Furosemide—dilated cardiomyopathy	0.00198	0.00207	CcSEcCtD
Rabeprazole—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00198	0.00206	CcSEcCtD
Rabeprazole—Anaemia—Lisinopril—dilated cardiomyopathy	0.00197	0.00205	CcSEcCtD
Rabeprazole—Angioedema—Lisinopril—dilated cardiomyopathy	0.00195	0.00203	CcSEcCtD
Rabeprazole—Malaise—Lisinopril—dilated cardiomyopathy	0.00192	0.002	CcSEcCtD
Rabeprazole—Vertigo—Lisinopril—dilated cardiomyopathy	0.00191	0.00199	CcSEcCtD
Rabeprazole—Syncope—Lisinopril—dilated cardiomyopathy	0.00191	0.00199	CcSEcCtD
Rabeprazole—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00191	0.00199	CcSEcCtD
Rabeprazole—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00191	0.00199	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.0019	0.00197	CcSEcCtD
Rabeprazole—Palpitations—Lisinopril—dilated cardiomyopathy	0.00188	0.00196	CcSEcCtD
Rabeprazole—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00187	0.00195	CcSEcCtD
Rabeprazole—Cough—Lisinopril—dilated cardiomyopathy	0.00186	0.00194	CcSEcCtD
Rabeprazole—Urticaria—Furosemide—dilated cardiomyopathy	0.00184	0.00192	CcSEcCtD
Rabeprazole—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00183	0.00191	CcSEcCtD
Rabeprazole—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00183	0.00191	CcSEcCtD
Rabeprazole—Chest pain—Lisinopril—dilated cardiomyopathy	0.00181	0.00189	CcSEcCtD
Rabeprazole—Myalgia—Lisinopril—dilated cardiomyopathy	0.00181	0.00189	CcSEcCtD
Rabeprazole—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00181	0.00189	CcSEcCtD
Rabeprazole—Anxiety—Lisinopril—dilated cardiomyopathy	0.00181	0.00188	CcSEcCtD
Rabeprazole—Discomfort—Lisinopril—dilated cardiomyopathy	0.00179	0.00187	CcSEcCtD
Rabeprazole—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00177	0.00185	CcSEcCtD
Rabeprazole—Confusional state—Lisinopril—dilated cardiomyopathy	0.00175	0.00183	CcSEcCtD
Rabeprazole—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00174	0.00181	CcSEcCtD
Rabeprazole—Oedema—Lisinopril—dilated cardiomyopathy	0.00174	0.00181	CcSEcCtD
Rabeprazole—Shock—Lisinopril—dilated cardiomyopathy	0.00171	0.00178	CcSEcCtD
Rabeprazole—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00171	0.00178	CcSEcCtD
Rabeprazole—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.0017	0.00177	CcSEcCtD
Rabeprazole—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0017	0.00177	CcSEcCtD
Rabeprazole—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00168	0.00175	CcSEcCtD
Rabeprazole—Asthenia—Furosemide—dilated cardiomyopathy	0.00166	0.00173	CcSEcCtD
Rabeprazole—Anorexia—Lisinopril—dilated cardiomyopathy	0.00166	0.00173	CcSEcCtD
Rabeprazole—Pruritus—Furosemide—dilated cardiomyopathy	0.00164	0.00171	CcSEcCtD
Rabeprazole—Hypotension—Lisinopril—dilated cardiomyopathy	0.00162	0.00169	CcSEcCtD
Rabeprazole—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00159	0.00165	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00158	0.00165	CcSEcCtD
Rabeprazole—Insomnia—Lisinopril—dilated cardiomyopathy	0.00157	0.00164	CcSEcCtD
Rabeprazole—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00156	0.00163	CcSEcCtD
Rabeprazole—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00155	0.00162	CcSEcCtD
Rabeprazole—Somnolence—Lisinopril—dilated cardiomyopathy	0.00155	0.00161	CcSEcCtD
Rabeprazole—Dizziness—Furosemide—dilated cardiomyopathy	0.00153	0.0016	CcSEcCtD
Rabeprazole—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00153	0.0016	CcSEcCtD
Rabeprazole—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00151	0.00158	CcSEcCtD
Rabeprazole—Pain—Lisinopril—dilated cardiomyopathy	0.00149	0.00155	CcSEcCtD
Rabeprazole—Constipation—Lisinopril—dilated cardiomyopathy	0.00149	0.00155	CcSEcCtD
Rabeprazole—Vomiting—Furosemide—dilated cardiomyopathy	0.00147	0.00154	CcSEcCtD
Rabeprazole—Rash—Furosemide—dilated cardiomyopathy	0.00146	0.00152	CcSEcCtD
Rabeprazole—Dermatitis—Furosemide—dilated cardiomyopathy	0.00146	0.00152	CcSEcCtD
Rabeprazole—Headache—Furosemide—dilated cardiomyopathy	0.00145	0.00151	CcSEcCtD
Rabeprazole—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00143	0.00149	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00142	0.00148	CcSEcCtD
Rabeprazole—Urticaria—Lisinopril—dilated cardiomyopathy	0.00138	0.00144	CcSEcCtD
Rabeprazole—Nausea—Furosemide—dilated cardiomyopathy	0.00138	0.00143	CcSEcCtD
Rabeprazole—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00137	0.00143	CcSEcCtD
Rabeprazole—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00137	0.00143	CcSEcCtD
Rabeprazole—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00128	0.00134	CcSEcCtD
Rabeprazole—Asthenia—Lisinopril—dilated cardiomyopathy	0.00125	0.0013	CcSEcCtD
Rabeprazole—Pruritus—Lisinopril—dilated cardiomyopathy	0.00123	0.00128	CcSEcCtD
Rabeprazole—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00119	0.00124	CcSEcCtD
Rabeprazole—Dizziness—Lisinopril—dilated cardiomyopathy	0.00115	0.0012	CcSEcCtD
Rabeprazole—Vomiting—Lisinopril—dilated cardiomyopathy	0.00111	0.00115	CcSEcCtD
Rabeprazole—Rash—Lisinopril—dilated cardiomyopathy	0.0011	0.00114	CcSEcCtD
Rabeprazole—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0011	0.00114	CcSEcCtD
Rabeprazole—Headache—Lisinopril—dilated cardiomyopathy	0.00109	0.00114	CcSEcCtD
Rabeprazole—Nausea—Lisinopril—dilated cardiomyopathy	0.00103	0.00108	CcSEcCtD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000832	0.0206	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00081	0.02	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00081	0.02	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000753	0.0186	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000742	0.0184	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000722	0.0179	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000722	0.0179	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000671	0.0166	CbGpPWpGaD
Rabeprazole—CYP1A1—PPARA activates gene expression—ANKRD1—dilated cardiomyopathy	0.000644	0.0159	CbGpPWpGaD
Rabeprazole—CYP1A1—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000631	0.0156	CbGpPWpGaD
Rabeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ANKRD1—dilated cardiomyopathy	0.00063	0.0156	CbGpPWpGaD
Rabeprazole—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000516	0.0128	CbGpPWpGaD
Rabeprazole—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000475	0.0117	CbGpPWpGaD
Rabeprazole—ATP4B—Ion channel transport—RAF1—dilated cardiomyopathy	0.000472	0.0117	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidative Stress—SOD2—dilated cardiomyopathy	0.000441	0.0109	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ANKRD1—dilated cardiomyopathy	0.000434	0.0107	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidative Stress—GPX1—dilated cardiomyopathy	0.000421	0.0104	CbGpPWpGaD
Rabeprazole—ATP4A—Ion channel transport—RAF1—dilated cardiomyopathy	0.000421	0.0104	CbGpPWpGaD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.000402	0.00995	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000291	0.0072	CbGpPWpGaD
Rabeprazole—CYP1A1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00028	0.00692	CbGpPWpGaD
Rabeprazole—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000229	0.00566	CbGpPWpGaD
Rabeprazole—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000209	0.00516	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000186	0.00459	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000182	0.0045	CbGpPWpGaD
Rabeprazole—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000178	0.00441	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000173	0.00428	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000173	0.00428	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000168	0.00417	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000168	0.00417	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000164	0.00406	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000163	0.00402	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000157	0.00387	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000146	0.00362	CbGpPWpGaD
Rabeprazole—CYP1A1—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.000145	0.00359	CbGpPWpGaD
Rabeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.000142	0.00351	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000142	0.0035	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000133	0.00329	CbGpPWpGaD
Rabeprazole—CYP1A1—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.00013	0.00323	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000129	0.00319	CbGpPWpGaD
Rabeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.000128	0.00316	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000125	0.00309	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000125	0.00309	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000121	0.003	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000119	0.00294	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000119	0.00294	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000116	0.00287	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000114	0.00282	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00011	0.00273	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—TAZ—dilated cardiomyopathy	0.000107	0.00265	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000104	0.00257	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	9.77e-05	0.00242	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SDHA—dilated cardiomyopathy	9.68e-05	0.00239	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	8.8e-05	0.00218	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	7.95e-05	0.00197	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	7.95e-05	0.00197	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ANKRD1—dilated cardiomyopathy	7.7e-05	0.00191	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	7.57e-05	0.00187	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	7.57e-05	0.00187	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	7.24e-05	0.00179	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	6.55e-05	0.00162	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	6.3e-05	0.00156	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	5.93e-05	0.00147	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	5.8e-05	0.00143	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	5.75e-05	0.00142	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	5.45e-05	0.00135	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	5.41e-05	0.00134	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	5.36e-05	0.00133	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	4.93e-05	0.00122	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	4.91e-05	0.00122	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	4.89e-05	0.00121	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	4.62e-05	0.00114	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	4.18e-05	0.00103	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4e-05	0.000989	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.89e-05	0.000963	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	3.79e-05	0.000938	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	3.56e-05	0.000882	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.5e-05	0.000867	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.42e-05	0.000845	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.27e-05	0.000809	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	3.22e-05	0.000798	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.18e-05	0.000788	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.98e-05	0.000738	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.9e-05	0.000718	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.87e-05	0.000709	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GPX1—dilated cardiomyopathy	2.63e-05	0.000651	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.61e-05	0.000647	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CD36—dilated cardiomyopathy	2.56e-05	0.000634	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.55e-05	0.00063	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.48e-05	0.000614	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AGT—dilated cardiomyopathy	2.31e-05	0.00057	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.23e-05	0.000553	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	1.78e-05	0.00044	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	1.73e-05	0.000429	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	1.56e-05	0.000386	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	1.46e-05	0.00036	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	1.42e-05	0.000351	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	1.34e-05	0.000331	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	1.33e-05	0.000329	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	1.3e-05	0.000323	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	1.29e-05	0.00032	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	1.28e-05	0.000316	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.17e-05	0.000291	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	1.16e-05	0.000288	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	1.13e-05	0.000281	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	1.11e-05	0.000273	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	9.95e-06	0.000246	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	8.76e-06	0.000217	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	8.53e-06	0.000211	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	7.68e-06	0.00019	CbGpPWpGaD
